Refractory malignant solid neoplasm Clinical Trials

Delta Trials catalogs 26 clinical trials for Refractory malignant solid neoplasm in its publicly accessible dataset. Within this set, 3 currently recruiting participants and 1 trial have reached completion. This research occurs across 819 participating sites around the world. An additional 22 trials are in other active phases such as not yet recruiting or pending status. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.